News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 2090 results

Amarin appeals ‘skinny label’ loss

US23-11-2022Staff Writer

Generic heart drug was found to not infringe Amarin’s blockbuster treatment earlier this year | Health insurer Health Net tied to case after allegedly promoting use of the generic.

Pharma owners warned of Brexit effect on TMs

UK22-11-2022Muireann Bolger

Large market for parallel or ‘grey’ imports of pharmaceuticals due to pricing differences in various countries | Govt consultation respondents unhappy with ‘lack of EU reciprocity’| Mewburn Ellis.

MSD makes $1.4bn bid on biopharma company

US22-11-2022Staff Writer

Move could garner ‘milestone’ treatment for one of MSD’s portfolios | Activity comes after a Spanish watchdog fined the pharma firm $39 million.

California firm entices quartet of litigators from rival

US17-11-2022Muireann Bolger

Life sciences practice boosted by four-partner ‘powerhouse’ team | Attorneys have all achieved notable trial outcomes for pharma companies.

Teva secures victory in iron overload treatment dispute

UK17-11-2022Staff Writer

Judge Hacon rules that a skilled team “would have thought it obvious” to reformulate drug into a tablet | Teva DFX patents also found not to infringe, falling outside the claims on both a normal construction and under the doctrine of equivalents.

Big pharma steps up access, but uneven progress made: report

Netherlands16-11-2022Staff Writer

Licensing of COVID-19 treatments has shifted to include other medicines and treatment areas | World’s largest pharma companies still “consistently overlook the poorest countries” | Report offers strategy to improve access.

Patent firms unveil joint UPC ‘powerhouse’

EU15-11-2022Muireann Bolger

Firms aim to form a UPC litigation alliance | New court has significant implications for life sciences | UPC faces calls for delay over concerns regarding its case management system.

FTC wades into escalating ‘Orange Book’ clash

US15-11-2022Staff Writer

Jazz accused a rival of infringement | Avadel filed a counterclaim seeking to delist the patent from the Orange Book.

SCOTUS rejects BMS vs Gilead patent clash

US10-11-2022Staff Writer

Dispute over patent relating to a CAR-T cell therapy shunned by top court | Backing from Amgen, GSK and St. Jude's Children's Research Hospital over “exceedingly narrow” patent protection fails to convince Justices.

SCOTUS agrees to hear Amgen revival bid

US07-11-2022Staff Writer

The dispute centres on a section of the Patent Act concerning 'enablement' | The US government had urged the court to deny the petition.

Showing 1 to 10 of 2090 results

LSIPR